271 related articles for article (PubMed ID: 19344414)
1. Risk of non-Hodgkin lymphoma in association with germline variation in complement genes.
Cerhan JR; Novak AJ; Fredericksen ZS; Wang AH; Liebow M; Call TG; Dogan A; Witzig TE; Ansell SM; Habermann TM; Kay NE; Slager SL
Br J Haematol; 2009 Jun; 145(5):614-23. PubMed ID: 19344414
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in complement system genes and risk of non-Hodgkin lymphoma.
Bassig BA; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Hu W; Leaderer B; Yeager M; Menashe I; Boyle P; Xu J; Zou K; Zhu Y; Chanock S; Rothman N; Lan Q
Environ Mol Mutagen; 2012 Mar; 53(2):145-51. PubMed ID: 22170086
[TBL] [Abstract][Full Text] [Related]
4. A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
Cerhan JR; Fredericksen ZS; Novak AJ; Ansell SM; Kay NE; Liebow M; Dogan A; Cunningham JM; Wang AH; Witzig TE; Habermann TM; Asmann YW; Slager SL
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1799-806. PubMed ID: 22911334
[TBL] [Abstract][Full Text] [Related]
5. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
Wang SS; Purdue MP; Cerhan JR; Zheng T; Menashe I; Armstrong BK; Lan Q; Hartge P; Kricker A; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Grulich A; Leaderer BP; Davis S; Cozen W; Yeager M; Chanock SJ; Chatterjee N; Rothman N
PLoS One; 2009; 4(4):e5360. PubMed ID: 19390683
[TBL] [Abstract][Full Text] [Related]
6. Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma.
Charbonneau B; Maurer MJ; Fredericksen ZS; Zent CS; Link BK; Novak AJ; Ansell SM; Weiner GJ; Wang AH; Witzig TE; Dogan A; Slager SL; Habermann TM; Cerhan JR
Am J Hematol; 2012 Sep; 87(9):880-5. PubMed ID: 22718493
[TBL] [Abstract][Full Text] [Related]
7. Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.
Kelly JL; Novak AJ; Fredericksen ZS; Liebow M; Ansell SM; Dogan A; Wang AH; Witzig TE; Call TG; Kay NE; Habermann TM; Slager SL; Cerhan JR
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2847-58. PubMed ID: 20855536
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.
Hu W; Bassig BA; Xu J; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Leaderer B; Yeager M; Menashe I; Boyle P; Zou K; Zhu Y; Chanock S; Lan Q; Rothman N
Environ Mol Mutagen; 2013 Jan; 54(1):72-7. PubMed ID: 23055202
[TBL] [Abstract][Full Text] [Related]
9. Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma.
Wang SS; Menashe I; Cerhan JR; Cozen W; Severson RK; Davis S; Hutchinson A; Rothman N; Chanock SJ; Bernstein L; Hartge P; Morton LM
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):42-9. PubMed ID: 21148756
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in the one-carbon metabolism pathway genes and susceptibility to non-Hodgkin lymphoma.
Suthandiram S; Gan GG; Mohd Zain S; Bee PC; Lian LH; Chang KM; Ong TC; Mohamed Z
Tumour Biol; 2015 Mar; 36(3):1819-34. PubMed ID: 25384508
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
Skibola CF; Bracci PM; Halperin E; Nieters A; Hubbard A; Paynter RA; Skibola DR; Agana L; Becker N; Tressler P; Forrest MS; Sankararaman S; Conde L; Holly EA; Smith MT
PLoS One; 2008 Jun; 3(7):e2816. PubMed ID: 18636124
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.
Lan Q; Wang SS; Menashe I; Armstrong B; Zhang Y; Hartge P; Purdue MP; Holford TR; Morton LM; Kricker A; Cerhan JR; Grulich A; Cozen W; Zahm SH; Yeager M; Vajdic CM; Schenk M; Leaderer B; Yuenger J; Severson RK; Chatterjee N; Chanock SJ; Zheng T; Rothman N
Br J Haematol; 2011 May; 153(3):341-50. PubMed ID: 21418175
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies.
Shen M; Menashe I; Morton LM; Zhang Y; Armstrong B; Wang SS; Lan Q; Hartge P; Purdue MP; Cerhan JR; Grulich A; Cozen W; Yeager M; Holford TR; Vajdic CM; Davis S; Leaderer B; Kricker A; Severson RK; Zahm SH; Chatterjee N; Rothman N; Chanock SJ; Zheng T
Br J Haematol; 2010 Nov; 151(3):239-44. PubMed ID: 20813000
[TBL] [Abstract][Full Text] [Related]
14. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis.
Kurreeman FA; Padyukov L; Marques RB; Schrodi SJ; Seddighzadeh M; Stoeken-Rijsbergen G; van der Helm-van Mil AH; Allaart CF; Verduyn W; Houwing-Duistermaat J; Alfredsson L; Begovich AB; Klareskog L; Huizinga TW; Toes RE
PLoS Med; 2007 Sep; 4(9):e278. PubMed ID: 17880261
[TBL] [Abstract][Full Text] [Related]
15. Associations between genetic variants in immunoregulatory genes and risk of non-Hodgkin lymphoma in a Chinese population.
Ye X; Zhao K; Wu C; Hu P; Fu H
Oncotarget; 2017 Feb; 8(6):10450-10457. PubMed ID: 28060727
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.
Purdue MP; Lan Q; Kricker A; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
Carcinogenesis; 2007 Mar; 28(3):704-12. PubMed ID: 17056605
[TBL] [Abstract][Full Text] [Related]
17. The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma.
Aissani B; Ogwaro KM; Shrestha S; Tang J; Breen EC; Wong HL; Jacobson LP; Rabkin CS; Ambinder RF; Martinez-Maza O; Kaslow RA
J Acquir Immune Defic Syndr; 2009 Oct; 52(2):170-9. PubMed ID: 19654554
[TBL] [Abstract][Full Text] [Related]
18. TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.
Plenge RM; Seielstad M; Padyukov L; Lee AT; Remmers EF; Ding B; Liew A; Khalili H; Chandrasekaran A; Davies LR; Li W; Tan AK; Bonnard C; Ong RT; Thalamuthu A; Pettersson S; Liu C; Tian C; Chen WV; Carulli JP; Beckman EM; Altshuler D; Alfredsson L; Criswell LA; Amos CI; Seldin MF; Kastner DL; Klareskog L; Gregersen PK
N Engl J Med; 2007 Sep; 357(12):1199-209. PubMed ID: 17804836
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut.
Shen M; Zheng T; Lan Q; Zhang Y; Zahm SH; Wang SS; Holford TR; Leaderer B; Yeager M; Welch R; Kang D; Boyle P; Zhang B; Zou K; Zhu Y; Chanock S; Rothman N
Hum Genet; 2006 Jul; 119(6):659-68. PubMed ID: 16738949
[TBL] [Abstract][Full Text] [Related]
20. Association of
Villegas M; Sciutto E; Rosetti M; Fleury A; Fragoso G
Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31570557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
